InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-1.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Lim Jonathan E, Director. Insider active across 4 companies, notably Erasca, Inc.. In total, 11 disclosures have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €4m. History available since 14 December 2022. The latest transaction was filed on 5 December 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
37,724 sharesCommon StockSEC:0001415889-25-002957:0
525,274 sharesCommon StockSEC:0000950170-24-041843:0
721,850 shares@ US$1.68728.3% of flowCommon StockSEC:0001209191-23-057681:0
Canonical exit: 4 Mar 2024 (T+90)
1,000,000 shares@ US$2.02648.4% of flowCommon StockSEC:0001209191-23-052403:0
Canonical exit: 3 Jan 2024 (T+90)
100,000 shares@ US$2.756.4% of flowCommon StockSEC:0001209191-23-035590:0
Canonical exit: 6 Sept 2023 (T+90)
100,000 shares@ US$2.846.6% of flowCommon StockSEC:0001209191-23-021458:0
Canonical exit: 26 Jun 2023 (T+90)
60,000 shares@ US$3.8575.4% of flowCommon StockSEC:0001209191-23-002802:0
Canonical exit: 10 Apr 2023 (T+90)
40,000 shares@ US$4.994.7% of flowCommon StockSEC:0001209191-22-061352:0
Canonical exit: 14 Mar 2023 (T+90)
5,135,390 sharesCommon StockSEC:0000899243-21-029085
5,135,390 sharesCommon StockSEC:0000899243-21-029085:0
72,000 sharesCommon StockSEC:0001209191-16-090805:0
11 of 11 declarations
About Lim Jonathan E
Jonathan E. Lim is a board member of Erasca, Inc. As a board member, he participates in overseeing the company's activities and making strategic decisions. Lim brings valuable insight through his experience in the biopharmaceutical sector, thereby contributing to the governance and direction of the company.
